can i take amoxicillin with semaglutide and Semaglutide: Drug Interaction Guide TrimRX | Balancing Health: Can

In the SURPASS-1 trial, TZP 10 mg resulted in a mean decrease in SBP of 5.2 mmHg, which is more significant than that with a placebo

Ozeki et al (2022) found that GLP1-RA semaglutide effectively reduces body adiposity while maintaining the skeletal muscle mass in obese Type 2 Diabetic patients. Xiang et al (2023) had similar findings, semaglutide can reduce the weight and fat of obese patients while effectively maintaining muscle mass and muscle strength. Chen et al (2023) conducted a 3-month intervention using dulaglutide in patients with Type 2 Diabetes, noting , dulaglutide intervention does not cause muscle and bone mass loss while inducing weight loss, and % change in body fat was independently associated with improved glucose control during dulaglutide therapy. With an increasing number of physicians and researchers relying on GLP-1 therapies for clinical care and research, it will continue to be crucial to track sensitive changes in body composition across different patient populations

This comprehensive approach underscores the importance of balancing the undeniable benefits of semaglutide with the need to mitigate adverse effects, including UTIs

BMJ Open 9 , e028238 (2019)

The first time we saw this was during the liraglutide trials where blood pressure reduction occurred within 2 weeks of initiation of therapy, which was before any meaningful weight benefit was demonstrated suggesting that weight loss is not the driver of the blood pressure benefits

[DOI] [PubMed] [Google Scholar] 25.Dorton H.M., Luo S., Monterosso J.R., Page K.A